CRIS Current Research Information System

TANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.391
AS - Asia 1.769
EU - Europa 1.669
AF - Africa 137
SA - Sud America 78
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.359
SG - Singapore 500
CN - Cina 487
VN - Vietnam 447
GB - Regno Unito 443
SE - Svezia 337
DE - Germania 215
IT - Italia 174
HK - Hong Kong 130
UA - Ucraina 96
RU - Federazione Russa 77
FR - Francia 75
IN - India 73
IE - Irlanda 67
BR - Brasile 47
CI - Costa d'Avorio 45
JO - Giordania 37
ZA - Sudafrica 37
HR - Croazia 31
NL - Olanda 30
JP - Giappone 29
TG - Togo 26
EE - Estonia 25
FI - Finlandia 24
KR - Corea 22
CA - Canada 20
CH - Svizzera 19
AR - Argentina 15
BE - Belgio 15
IR - Iran 12
NG - Nigeria 12
BG - Bulgaria 9
ES - Italia 9
SC - Seychelles 9
PL - Polonia 8
EC - Ecuador 7
TR - Turchia 7
ID - Indonesia 6
MX - Messico 5
AT - Austria 4
GR - Grecia 4
TN - Tunisia 4
CL - Cile 3
LB - Libano 3
TW - Taiwan 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
IL - Israele 2
IQ - Iraq 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KE - Kenya 1
LT - Lituania 1
MA - Marocco 1
NO - Norvegia 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
UY - Uruguay 1
Totale 6.049
Salva come PNG Salva come JPEG
Città #
Southend 382
Singapore 341
Fairfield 253
Ashburn 219
Chandler 219
Houston 167
Ann Arbor 155
Woodbridge 132
Hong Kong 128
Seattle 119
Wilmington 107
Cambridge 89
Dong Ket 82
Beijing 80
Ho Chi Minh City 79
Hefei 76
Princeton 76
Santa Clara 74
Dublin 67
Jacksonville 65
Boardman 62
Hanoi 54
Los Angeles 51
Abidjan 45
Nanjing 43
Amman 37
Westminster 36
Turin 35
Padova 34
New York 33
Lomé 26
Berlin 23
Tokyo 23
Munich 22
Seoul 22
Buffalo 20
Helsinki 19
Saint Petersburg 19
Jinan 18
Changsha 17
Shenyang 16
Bologna 14
San Diego 14
Milan 13
Nanchang 13
Redwood City 13
Abeokuta 12
Bremen 12
Brussels 12
Jiaxing 12
Bern 11
Frankfurt am Main 11
Florence 10
Guangzhou 10
Mülheim 10
Zhengzhou 10
Falkenstein 9
Sofia 9
Hangzhou 8
Hebei 8
Lauterbourg 8
Norwalk 8
São Paulo 8
Da Nang 7
Dearborn 7
Taizhou 7
Tianjin 7
Zanjan 7
Düsseldorf 6
Falls Church 6
Hải Dương 6
London 6
Phoenix 6
Quito 6
Biên Hòa 5
Chicago 5
Dallas 5
Ha Long 5
Haiphong 5
Izumo 5
Johannesburg 5
Mahé 5
Quận Bình Thạnh 5
Redmond 5
Redondo Beach 5
Rome 5
San Jose 5
Warsaw 5
Wuhan 5
Ankara 4
Harbin 4
Kunming 4
Lausanne 4
Ninh Bình 4
Orem 4
Portsmouth 4
San Francisco 4
Turku 4
Verona 4
Amsterdam 3
Totale 3.989
Salva come PNG Salva come JPEG
Nome #
Effectiveness of Fludarabine, Idarubicin and Cyclophosphade (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin’s Lymphoma. 241
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. 227
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. 226
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients. 216
A phase 2 trial of fludarabine and mitoxantrone chemoterapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma 211
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphoma. 208
18 F-FDG PET in malignant lymphoma: significance of positive findings 208
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 197
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 196
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience 190
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. 182
Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study 175
Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. 171
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 171
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 170
Phase II trial of temozolomide in patients with pretreated cutaneous T-cell lymphoma. 168
Discordant response to chemotherapy: An unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients 164
Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients 162
Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy. 155
Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas. 148
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 147
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma. 146
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma 146
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. 145
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma. 145
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 144
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 143
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. 138
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study) 138
FDG PET and 90Y ibritumomab tiuxetan in patients with follicular lymphoma. 132
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. 132
Safety and Efficacy of Single-Agent Bendamustine After Failure of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin's Lymphoma: Experience With 27 Patients. 126
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ). 126
FDG-PET in the serial assessment of patinets with lymphoma in complete remission 125
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine 122
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia. 120
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma 59
Lenalidomide plus rituximab for the initial treatment of elderly frail patients with DLBCL: the FIL_ReRi Phase 2 Study 59
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 54
Totale 6.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 92 5 39 52 30 47 155
2021/2022916 194 21 65 117 57 47 17 48 21 47 180 102
2022/2023948 107 108 54 115 69 84 20 37 211 29 72 42
2023/2024195 13 44 8 27 15 51 5 10 5 8 2 7
2024/2025856 28 168 75 47 162 47 55 11 4 67 18 174
2025/20261.066 160 279 161 110 243 113 0 0 0 0 0 0
Totale 6.133